92 related articles for article (PubMed ID: 1809075)
41. Determination of oestrogen receptors by enzyme immunoassay. Technical differences between laboratories and their consequences.
Romain S; Formento JL; Guirou O; Francoual M; Milano G; Martin PM
Eur J Cancer; 1994; 30A(6):740-6. PubMed ID: 7917530
[TBL] [Abstract][Full Text] [Related]
42. A comparative study of radioligand (DCC) and modified immunoperoxidase anti-estrogen receptor techniques in breast carcinoma.
Kerner H; Zilberman M; Israeli E; Lichtig C
Isr J Med Sci; 1994 Jul; 30(7):506-9. PubMed ID: 7519589
[TBL] [Abstract][Full Text] [Related]
43. Twenty years of experience with the steroid receptor external quality assessment program - the paradigm for tumour biomarker EQA studies. On behalf of the EROTC Receptor and Biomarker Study Group.
Geurts-Moespot J; Leake R; Benraad TJ; Sweep CG
Int J Oncol; 2000 Jul; 17(1):13-22. PubMed ID: 10853012
[TBL] [Abstract][Full Text] [Related]
44. Standardization of steroid receptor assays in human breast cancer--III. Selection of reference material for intra- and inter-laboratory quality control.
Thorpe SM; Koenders A
Eur J Cancer Clin Oncol; 1986 Aug; 22(8):939-44. PubMed ID: 3770051
[TBL] [Abstract][Full Text] [Related]
45. Interlaboratory comparison of oestrogen receptor data.
Thorpe SM
Eur J Cancer; 1994; 30A(6):730-2. PubMed ID: 7917528
[No Abstract] [Full Text] [Related]
46. EORTC external quality assurance program for ER and PgR measurements: trial 1998/1999. European Organisation for Research and Treatment of Cancer.
Sweep CG; Geurts-Moespot J
Int J Biol Markers; 2000; 15(1):62-9. PubMed ID: 10763143
[TBL] [Abstract][Full Text] [Related]
47. Determination of oestrogen receptors: application of the Passing-Bablock linear regression technique for comparison of enzyme immunoassay and radioligand binding assay in 1841 breast cancer tumours.
Romain S; Dussert C; Martin PM
Eur J Cancer; 1991; 27(6):715-20. PubMed ID: 1829910
[TBL] [Abstract][Full Text] [Related]
48. [Determination of estradiol receptors by immunoenzyme technique and by radioligand binding in 2134 breast tumors].
Romain S; Dussert C; Martin PM
Bull Cancer; 1991; 78(4):331-40. PubMed ID: 1713518
[TBL] [Abstract][Full Text] [Related]
49. Hormone receptor assays: clinical usefulness in the management of carcinoma of the breast.
Jordan VC; Wolf MF; Mirecki DM; Whitford DA; Welshons WV
Crit Rev Clin Lab Sci; 1988; 26(2):97-152. PubMed ID: 2852576
[TBL] [Abstract][Full Text] [Related]
50. Comparison of sex steroid receptor determinations in human breast cancer by enzyme immunoassay and radioligand binding.
Pasic R; Djulbegovic B; Wittliff JL
J Clin Lab Anal; 1990; 4(6):430-6. PubMed ID: 2283562
[TBL] [Abstract][Full Text] [Related]
51. Effects of the presence of progesterone receptors on the relationship between enzyme immunoassay and steroid-binding assay for oestrogen receptors.
Marsigliante S; Puddefoot J; Vinson GP; Gilmore OJ
Biochem Soc Trans; 1990 Aug; 18(4):565-6. PubMed ID: 2276439
[No Abstract] [Full Text] [Related]
52. A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas.
Detre S; Saclani Jotti G; Dowsett M
J Clin Pathol; 1995 Sep; 48(9):876-8. PubMed ID: 7490328
[TBL] [Abstract][Full Text] [Related]
53. Quality assurance for steroid receptor assay in human breast cancer: six years experience of the Italian Committee.
Piffanelli A; Pelizzola D; De Bortoli M; Agrimonti F; Frairia R; Giovannini G; Fumero S
Tumori; 1985 Dec; 71(6):589-95. PubMed ID: 4082292
[TBL] [Abstract][Full Text] [Related]
54. Reliability of steroid hormone receptor assays: an international study.
Jordan VC; Zava DT; Eppenburger U; Kiser A; Sebek S; Dowdle E; Krozowski Z; Bennett RC; Funder J; Holdaway IM; Wittliff JL
Eur J Cancer Clin Oncol; 1983 Mar; 19(3):357-63. PubMed ID: 6683173
[TBL] [Abstract][Full Text] [Related]
55. Quality control of estrogen receptor assays in The Netherlands.
Koenders T; Benraad TJ
Breast Cancer Res Treat; 1983; 3(3):255-66. PubMed ID: 6367854
[TBL] [Abstract][Full Text] [Related]
56. A multicentre study into the reliability of steroid receptor immunocytochemical assay quantification. British Quality Control Group.
McClelland RA; Wilson D; Leake R; Finlay P; Nicholson RI
Eur J Cancer; 1991; 27(6):711-5. PubMed ID: 1829909
[TBL] [Abstract][Full Text] [Related]
57. Results of the Italian interlaboratory quality control program for estradiol receptor assay.
Fumero S; Berruto GP; Pelizzola D; Grilli S; Buttazzi C; Di Fronzo G; Ronchi E; Bozzetti C; Mori P; Concolino G; Marocchi A; Robustelli Della Cuna G; Zibera C; Cerrutti G; Ros A; Piffanelli A
Tumori; 1981 Aug; 67(4):301-6. PubMed ID: 7198312
[TBL] [Abstract][Full Text] [Related]
58. Improvement of quality control for steroid receptor measurements: analysis of distributions in more than 40000 primary breast cancers. French Study Group on Tissue and Molecular Biopathology.
Romain S; Spyratos F; Goussard J; Formento JL; Magdelénat H
Breast Cancer Res Treat; 1996; 41(2):131-9. PubMed ID: 8944331
[TBL] [Abstract][Full Text] [Related]
59. Modeling Canadian Quality Control Test Program for Steroid Hormone Receptors in Breast Cancer: Diagnostic Accuracy Study.
Pérez T; Makrestsov N; Garatt J; Torlakovic E; Gilks CB; Mallett S
Appl Immunohistochem Mol Morphol; 2016; 24(10):679-687. PubMed ID: 26200834
[TBL] [Abstract][Full Text] [Related]
60. Quality control program for estradiol receptor determination: the Italian experience.
Piffanelli A; Fumero S; Pelizzola D
Recent Results Cancer Res; 1984; 91():104-9. PubMed ID: 6729206
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
